Heritage Pharmaceuticals, a generic pharmaceutical company headquartered in New Jersey, was charged with conspiring with competitors to fix prices, rig bids, and allocate customers.
Joe Mont
Posted inRegulatory Policy
Not just blowing smoke: Time to take cannabis compliance seriously
As cannabis legalization spreads, so too do the risks and challenges for businesses.
Posted inRegulatory Enforcement
Reps urge White House to support blockchain
Bipartisan members of Congress are urging the Trump administration to throw its tech focus onto blockchain.
Posted inFinancial Services
U.S., U.K. launch Financial Innovation Partnership
A newly formalized partnership between the United States and United Kingdom aims to embolden innovation in financial services.
Posted inRegulatory Enforcement
SEC to hold roundtable on public marketplace
Coming this summer: An SEC roundtable for the public and SEC staff to discuss short-term and long-term management, the periodic reporting system, and SEC regulations.
Posted inRegulatory Policy
Commerce unveils new attack on ‘currency manipulation’
The Department of Commerce has issued a notice of proposed rulemaking to impose countervailing duties on countries that act to undervalue their currency relative to the dollar.
Posted inFinancial Services
FSB continues push for Legal Entity Identifiers
The United States is among the laggards when it comes to international identifying codes for financial entities.
Posted inBoards & Shareholders
Companies prioritize director experience
New research from the Conference Board says that despite a desire for diverse skillsets, companies continue to value prior board experience in their director selection.
Posted inRegulatory Policy
GAO suggests supervisory improvements for bank regulators
Is there a better way for bank regulators to conduct their supervisory and remediation processes? Congress’ GAO developed a rundown of suggestions and best practices in a report released this week.
Posted inData Privacy
Major changes to California privacy law likely scuttled
An initiative to strengthen and enhance the California Consumer Privacy Act was basically left for dead in that state’s legislature.